Luminescent ATP Assays: Transforming Translational Cell Viab
2026-05-25
This article explores how ultra-sensitive luciferase-based ATP cell viability assays, exemplified by APExBIO's Luminescent ATP Cell Viability Assay Kit I, drive mechanistic discovery and translational progress in cancer research. Blending biological rationale, cross-study evidence, and strategic workflow guidance, the article demonstrates how advanced cell viability measurement tools empower researchers to decode cytostatic effects, optimize delivery platforms, and elevate the reproducibility of preclinical findings.
(+)-Bicuculline: Technical Protocols for GABAA Antagonist Us
2026-05-25
(+)-Bicuculline is a well-characterized GABAA receptor antagonist used to dissect inhibitory neurotransmission and probe synaptic NMDA receptor signaling modulation in neuroscience research. It is not intended for diagnostic or clinical applications and requires careful attention to solubility and storage protocols for reliable results.
EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Precision Tools for Nanopar
2026-05-24
Discover how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) advances nanoparticle-mediated mRNA delivery research with dual fluorescence and immune-evasive chemistry. Explore protocol insights and translational lessons from recent breakthroughs in overcoming therapeutic resistance.
Neuromedin S (rat): Technical Guidance for GPCR Assays
2026-05-23
Neuromedin S (rat) provides a chemically defined reagent for controlled activation of neuromedin U receptor signaling in GPCR/G protein research. It enables reproducible studies of energy homeostasis and stress response in rat-based laboratory workflows. This product is not suitable for diagnostic, therapeutic, or clinical applications.
Everolimus (RAD001): Translating mTOR Inhibition into Cancer
2026-05-22
This thought-leadership article provides a mechanistic and strategic perspective on leveraging Everolimus (RAD001) as a precision mTOR pathway inhibitor in translational oncology. Integrating recent advances in in vitro drug response evaluation, it guides researchers in designing robust, informative cancer studies, including practical protocol parameters and a critical look at assay selection. The article distinguishes itself by connecting molecular pharmacology, experimental rigor, and translational value, while exemplifying APExBIO’s commitment to enabling next-generation cancer research.
Advances in Plant Protein Secretion: Protocols and Endomembr
2026-05-22
The reference work delivers a comprehensive update on plant protein secretion, highlighting both conventional and unconventional pathways and their specific features in plant systems. By compiling rigorously tested, step-by-step protocols, the book provides researchers with reliable experimental frameworks critical for advancing plant cell biology and comparative secretory system studies.
Phenothiazines Enhance Macrophage Antibacterial Defense via
2026-05-21
The reference study establishes that phenothiazines, including promethazine hydrochloride, significantly potentiate macrophage antibacterial activity by inducing reactive oxygen species (ROS) and autophagy. These findings clarify the mechanistic basis for host-directed therapies and offer new research directions in immunology and intracellular infection control.
N3-kethoxal: Next-Generation Probe for RNA Structure Mapping
2026-05-21
N3-kethoxal (3-(2-azidoethoxy)-1,1-dihydroxybutan-2-one) stands apart as a membrane-permeable, azide-functionalized nucleic acid probe enabling rapid, high-specificity mapping of RNA and single-stranded DNA. Its unique chemistry empowers both in vitro and in vivo workflows, streamlining bioorthogonal labeling, CRISPR off-target profiling, and RNA-protein interaction discovery.
Mdivi-1: Selective DRP1 Inhibitor for Mitochondrial Dynamics
2026-05-20
Mdivi-1, offered by APExBIO, empowers researchers to dissect mitochondrial fission with unprecedented selectivity in both cellular and in vivo models. This article details actionable workflows, troubleshooting strategies, and advanced applications for this selective DRP1 inhibitor—bridging recent ECM-mitochondria insights with robust experimental design.
Ferrocenyl Novobiocin Derivatives: Antimalarial and Anticanc
2026-05-20
This study presents the synthesis and biological evaluation of ferrocenyl and organic novobiocin derivatives, targeting both Plasmodium falciparum and breast cancer cells. The incorporation of ferrocene into the novobiocin scaffold enhanced antiparasitic and anticancer activities, offering new insights for drug design against resistant pathogens and tumors.
Fluconazole: Advanced Antifungal Workflows and Biofilm Resis
2026-05-19
Fluconazole, a potent fungal cytochrome P450 enzyme 14α-demethylase inhibitor, is transforming antifungal susceptibility testing and resistance research. This article delivers protocol-anchored guidance, highlights experimental innovations, and translates cutting-edge findings on biofilm resistance into actionable laboratory strategies.
Angiotensin (1-7) for Reliable Cell-Based Assays: Practical
2026-05-19
This article examines laboratory challenges in cell viability, proliferation, and cytotoxicity studies, illustrating how Angiotensin (1-7) (SKU A1041) delivers data-backed solutions. By addressing protocol optimization, data interpretation, and vendor reliability, we present evidence-driven guidance for maximizing experimental reproducibility and efficiency with this Mas receptor agonist.
Crizotinib Hydrochloride: Transforming Tumor Assembloid Rese
2026-05-18
Explore how Crizotinib hydrochloride advances cancer biology by enabling mechanistic dissection of oncogenic kinase signaling in next-generation tumor assembloid models. This article delivers strategic, evidence-based insights for translational researchers seeking to bridge the gap between molecular targeting and patient-relevant cancer models, with a focus on optimizing experimental design and translational impact.
Regulation and Vulnerability of the Toxoplasma gondii Cyst W
2026-05-18
This study elucidates the molecular regulation of cyst wall formation in Toxoplasma gondii, emphasizing the roles of GRA2 phosphorylation and the phosphatase PPM3C in determining cyst stability and protein localization. These findings inform experimental strategies for investigating parasite persistence and highlight methodological considerations for accurate nucleic acid detection in related workflows.
Hesperadin: Advanced Aurora B Kinase Inhibitor for Cell Cycl
2026-05-17
Hesperadin offers unmatched specificity as an ATP-competitive Aurora B kinase inhibitor, enabling precise dissection of mitotic checkpoints and chromosome segregation. Its robust phenotypes and compatibility with advanced experimental assays make it a cornerstone in cancer research and cell cycle regulation.
467 records 18/32 page Previous Next First page 上5页 1617181920 下5页 Last page